Trial Profile
Efficacy and safety of Tenofovir disoproxil fumarate in patients with chronic hepatitis B genotype C; Real-life practice from South Korea
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2015
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 22 Sep 2015 New trial record
- 12 Sep 2015 Results published in the International Journal of Clinical Pharmacy
- 12 Sep 2015 Results published in the International Journal of Clinical Pharmacy.